| Jena Danielle Parson, CNM | |
|
2450 Ashby Ave, Berkeley, CA 94705-2067 | |
| (510) 204-3977 | |
| (510) 204-5429 |
| Full Name | Jena Danielle Parson |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 2450 Ashby Ave, Berkeley, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568584035 | NPI | - | NPPES |
| NM1835 | Other | CA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | NMW 1835 (California) | Primary |
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today responded to Medafor's allegation that it has repudiated the Exclusive Distribution Agreement between the two companies.
The novel coronavirus has rapidly infected millions over the world in over 187 countries and territories, causing hundreds of thousands of deaths. One of the often-neglected and under-reported symptoms of the virus is the loss of the sense of smell or anosmia. Now, a new study out of Germany published on the preprint server medRxiv in April 2020 provides a quantified estimate of the magnitude of anosmia as a symptom of the coronavirus.
Antibodies that exist in the joints before the onset of rheumatoid arthritis can cause pain even in the absence of arthritis, researchers from Karolinska Institutet in Sweden report.
Medication commonly used to treat attention-deficit hyperactivity disorder (ADHD) may be effective for treatment of hyperactivity symptoms in children with autism and related pervasive developmental disorders, according to a study in the November issue of Archives of General Psychiatry.
› Verified 5 days ago
| Entity Name | Sutter Valley Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669846986 PECOS PAC ID: 9830094515 Enrollment ID: O20090311000335 |
News Archive
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today responded to Medafor's allegation that it has repudiated the Exclusive Distribution Agreement between the two companies.
The novel coronavirus has rapidly infected millions over the world in over 187 countries and territories, causing hundreds of thousands of deaths. One of the often-neglected and under-reported symptoms of the virus is the loss of the sense of smell or anosmia. Now, a new study out of Germany published on the preprint server medRxiv in April 2020 provides a quantified estimate of the magnitude of anosmia as a symptom of the coronavirus.
Antibodies that exist in the joints before the onset of rheumatoid arthritis can cause pain even in the absence of arthritis, researchers from Karolinska Institutet in Sweden report.
Medication commonly used to treat attention-deficit hyperactivity disorder (ADHD) may be effective for treatment of hyperactivity symptoms in children with autism and related pervasive developmental disorders, according to a study in the November issue of Archives of General Psychiatry.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jena Danielle Parson, CNM 325 Distel Cir, Los Altos, CA 94022-1408 Ph: (510) 204-3977 | Jena Danielle Parson, CNM 2450 Ashby Ave, Berkeley, CA 94705-2067 Ph: (510) 204-3977 |
News Archive
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today responded to Medafor's allegation that it has repudiated the Exclusive Distribution Agreement between the two companies.
The novel coronavirus has rapidly infected millions over the world in over 187 countries and territories, causing hundreds of thousands of deaths. One of the often-neglected and under-reported symptoms of the virus is the loss of the sense of smell or anosmia. Now, a new study out of Germany published on the preprint server medRxiv in April 2020 provides a quantified estimate of the magnitude of anosmia as a symptom of the coronavirus.
Antibodies that exist in the joints before the onset of rheumatoid arthritis can cause pain even in the absence of arthritis, researchers from Karolinska Institutet in Sweden report.
Medication commonly used to treat attention-deficit hyperactivity disorder (ADHD) may be effective for treatment of hyperactivity symptoms in children with autism and related pervasive developmental disorders, according to a study in the November issue of Archives of General Psychiatry.
› Verified 5 days ago
Eva L. Goodfriend-reano, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2216 Mcgee Ave, Berkeley, CA 94703 Phone: 510-848-1352 Fax: 510-323-2361 | |
Aimee Tom, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3010 Colby St, Berkeley, CA 94705 Phone: 510-882-2137 | |
Ms. Sallie Peters Hill, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2450 Ashby Ave, Berkeley, CA 94705 Phone: 510-204-3977 Fax: 510-204-5429 | |
Ms. Lauren L. Galaty, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2001 Dwight Way, Berkeley Primary Care, Room 1363, Berkeley, CA 94704 Phone: 510-204-4637 | |
Kassandra Marie Donnels, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave, Berkeley, CA 94705 Phone: 510-204-4444 | |
Kristen Park, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2404 Dana St, Apt B, Berkeley, CA 94704 Phone: 408-636-8431 | |
Mrs. Lior Mayer, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2450 Ashby Ave, Berkeley, CA 94705 Phone: 510-204-3977 Fax: 510-204-5129 |